Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T21447
(Former ID: TTDNS00559)
|
|||||
Target Name |
Glutamine receptor (GluR)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Successful target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Nasopharyngitis [ICD-11: CA00] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Approved Drug(s) | [+] 1 Approved Drugs | + | ||||
1 | L-alanyl-l-glutamine | Drug Info | Approved | Mucositis | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | L-alanyl-l-glutamine | Drug Info | [1], [3] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. | |||||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||||
REF 3 | Synthesis and application of dipeptides; current status and perspectives. Appl Microbiol Biotechnol. 2008 Nov;81(1):13-22. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.